Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Cognition Therapeutics和其他两只低于2美元的股票内部人士正在买入
The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周四收盘下跌超过100点。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
Blue Star Foods
蓝星食品
- The Trade: Blue Star Foods Corp. (NASDAQ:BSFC) Director Nubar Herian acquired a total of 219,611 shares an average price of $0.14. To acquire these shares, it cost around $30,636.
- What's Happening: On Feb. 21, Blue Star Foods signed a master service agreement with a seafood value added provider.
- What Blue Star Foods Does: Blue Star Foods Corp is an international seafood company based in Miami. It imports, packages, and sells refrigerated pasteurized crab meat, and other premium seafood products.
- 交易：蓝星食品公司（纳斯达克股票代码：BSFC）董事努巴尔·赫里安 共收购了219,611股股票 平均价格为0.14美元。收购这些股票的成本约为30,636美元。
- 发生了什么：2月21日，蓝星食品与一家海鲜增值供应商签署了主服务协议。
- 蓝星食品做什么：蓝星食品公司是一家总部位于迈阿密的国际海鲜公司。它进口、包装和销售冷藏巴氏消毒蟹肉和其他优质海鲜产品。
Ekso Bionics
Ekso Bionics
- The Trade: Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Director Corinna Lathan acquired a total of 13,733 shares at at an average price of $1.13. To acquire these shares, it cost around $15,477.
- What's Happening: On March 4, Ekso Bionics reported mixed fourth-quarter financial results.
- What Ekso Bionics Does: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets.
- 交易：Ekso Bionics Holdings, Inc.（纳斯达克股票代码：EKSO）董事科琳娜·拉森 共收购了13,733股股票 平均价格为1.13美元。收购这些股票的成本约为15,477美元。
- 发生了什么：3月4日，Ekso Bionics公布的第四季度财务业绩喜忧参半。
- Ekso Bionics做什么：Ekso Bionics Holdings Inc设计、开发和销售用于医疗保健和工业市场的外骨骼技术。
Cognition Therapeutics
认知疗法
- The Trade: Cognition Therapeutics, Inc. (NASDAQ:CGTX) CEO and President Lisa Ricciardi acquired a total of 5,700 shares at an average price of $1.75. The insider spent around $9,975 to buy those shares.
- What's Happening: Cognition Therapeutics announced closing of $11.5 million public offering of common stock.
- What Cognition Therapeutics Does: Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
- 交易：Cognition Therapeutics, Inc.（纳斯达克股票代码：CGTX）首席执行官兼总裁丽莎·里查迪 共收购了5,700股股票 平均价格为1.75美元。知情人士花费了约9,975美元购买了这些股票。
- 发生了什么：Cognition Therapeutics宣布完成1150万美元的普通股公开发行。
- Cognition Therapeutics做什么：Cognition Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现和开发针对年龄相关退行性疾病以及中枢神经系统和视网膜障碍的创新小分子疗法。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道
资讯热榜
更新时间